Lv11
80 积分 2024-06-14 加入
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
6小时前
已完结
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial
6小时前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
7小时前
已完结
Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study
7天前
已完结
1984 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
7天前
已完结
Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials
7天前
已完结
Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study
7天前
已完结
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
18天前
已完结
Efficacy and safety of Shexiang Baoxin Pill in patients with angina and non-obstructive coronary arteries: a multicenter, randomized, double-blind, placebo-controlled, phase Ⅳ clinical trial
20天前
已完结
Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
20天前
已关闭
皖公网安备34019202002308
